# Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities

> **NCT00255840** · NA · COMPLETED · sponsor: **CIPRA SA** · enrollment: 812 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BEHAVIORAL:** Monitoring by an HIV-trained medical doctor
- **BEHAVIORAL:** Monitoring by an HIV-trained primary care nurse
- **DRUG:** Efavirenz
- **DRUG:** Lamivudine
- **DRUG:** Lopinavir/Ritonavir
- **DRUG:** Nevirapine
- **DRUG:** Stavudine

## Key facts

- **NCT ID:** NCT00255840
- **Lead sponsor:** CIPRA SA
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 812 (ACTUAL)
- **Last updated:** 2011-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255840, "Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00255840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*